Oops, looks like you need to register to access this feature.
Select “Keep Exploring” to look around Scholars in Medicine. You have full access to all videos and podcasts for a limited time. Registration is provided at no cost exclusively for healthcare providers.
Sign Up or Log In
SIM - Scholars in Medicine Logo
Login
SIM - Scholars in Medicine Logo
Founding Sponsors
Register

Eosinophilic Esophagitis Update

Drug Profile
Budesonide Capsule
Drug Profile
Budesonide 6mg, 9mg ER Capsule
Drug Profile
Budesonide 9mg ER MMX Tablet, 2mg Rectal Foam
Drug Profile
Dupilumab
Drug Profile
Benralizumab
Drug Profile
Vedolizumab 108mg injection/300mg infusion
Drug Profile
Etrasimod 2mg Tablet
Drug Profile
fluticasone propionate
Drug Profile
Tezepelumab-ekko
Drug Profile
nicotine
Drug Profile
PIRFENIDONE
Drug Profile
Barzolvolimab
Drug Profile
Cendakimab
Evan Dellon, MD, MPH UNC School of Medicine

Dr. Dellon’s main clinical focus is on disorders of swallowing, and in particular eosinophilic esophagitis (EoE) and the other eosinophilic gastrointesintal disorders (EGIDs). His main research interest is also in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of EoE and the EGIDs. The goal of his research is to improve the lives of patients with EoE and EGIDs by learning how to better diagnose, treat, and monitor the condition. He is widely published in this area, and collaborates with investigators all over the world. Dr. Dellon has received research funding from the National Institutes of Health, the American College of Gastroenterology, the American Gastroenterologic Association, the CURED Foundation, UNC, and a number of industry partners to study EoE and other EGIDs.

Please Sign up or Login to access this feature.
Please Sign up or Login to access this feature.

Ask the Expert

Recent Questions

There are no questions yet.

1. Which of the following conditions is characterized by dense eosinophilia of the esophageal mucosa?

Select only 1 answer.

  1. A. Barrett's esophagus
  2. B. Eosinophilic esophagitis
  3. C. Gastroesophageal reflux disease (GERD)
  4. D. Achalasia

2. Which dietary elimination was found to be potentially as effective as the six-food elimination diet for eosinophilic esophagitis?

Select only 1 answer.

  1. A. Wheat elimination
  2. B. Soy elimination
  3. C. Animal milk elimination
  4. D. Peanut and tree nuts elimination

3. What is TC-325 primarily used for in gastroenterology?

Select only 1 answer.

  1. A. Treating Crohn's disease
  2. B. Managing irritable bowel syndrome (IBS)
  3. C. Controlling gastrointestinal tumor bleeding
  4. D. Treating Helicobacter pylori infection

4. Which somatostatin analog is used in the treatment of refractory angiodysplasia-related bleeding in the GI tract?

Select only 1 answer.

  1. A. Octreotide
  2. B. Somatropin
  3. C. Lanreotide
  4. D. Vapreotide

5. What is the primary treatment for irritable bowel syndrome (IBS) according to the literature?

Select only 1 answer.

  1. A. Proton pump inhibitors
  2. B. Dietary changes and lifestyle advice
  3. C. Antibiotics
  4. D. Biologic therapy

6. Which group was found to be more effective in achieving immediate hemostasis in the treatment of GI tumor bleeding?

Select only 1 answer.

  1. A. Standard endoscopic treatment
  2. B. TC-325
  3. C. Surgical intervention
  4. D. Proton pump inhibitors

7. What was the dosage of octreotide used in the OCEAN study for AVM bleeding?

Select only 1 answer.

  1. A. 10 mg every 4 weeks
  2. B. 20 mg every 2 weeks
  3. C. 40 mg every 28 days
  4. D. 50 mg every month

8. Which study finding supported the use of low-dose amitriptyline in primary care for IBS patients?

Select only 1 answer.

  1. A. Significant improvement in depression scores
  2. B. Significant reduction in IBS symptoms
  3. C. Increased referrals to gastroenterologists
  4. D. Better sleep quality